Literature DB >> 1333686

Active protection of mice against Salmonella typhi by immunization with strain-specific porins.

A Isibasi1, V Ortiz-Navarrete, J Paniagua, R Pelayo, C R González, J A García, J Kumate.   

Abstract

NIH mice were immunized with between 2.5 and 30 micrograms of two highly purified porins, 34 kDa and 36 kDa, isolated from the virulent strain Salmonella typhi 9,12, Vi:d. Of mice immunized with 10 micrograms of porins, 90% were protected against a challenge with up to 500 LD50 (50% lethal doses) of S. typhi 9,12,Vi:d and only 30% protection was observed in mice immunized with the same dose of porins but challenged with the heterologous strain Salmonella typhimurium. These results demonstrate the utility of porins for the induction of a protective status against S. typhi in mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333686     DOI: 10.1016/0264-410x(92)90041-h

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Two Salmonella OmpC K(b)-restricted epitopes for CD8+-T-cell recognition.

Authors:  Alberto Diaz-Quiñonez; Natalia Martin-Orozco; Armando Isibasi; Vianney Ortiz-Navarrete
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties.

Authors:  Mario A Moreno-Eutimio; Alejandra Tenorio-Calvo; Rodolfo Pastelin-Palacios; Christian Perez-Shibayama; Cristina Gil-Cruz; Rubén López-Santiago; Isabel Baeza; Marcos Fernández-Mora; Laura Bonifaz; Armando Isibasi; Edmundo Calva; Constantino López-Macías
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

3.  Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response.

Authors:  Ismael Secundino; Constantino López-Macías; Luisa Cervantes-Barragán; Cristina Gil-Cruz; Nora Ríos-Sarabia; Rodolfo Pastelin-Palacios; Miguel Angel Villasis-Keever; Ingeborg Becker; José Luis Puente; Edmundo Calva; Armando Isibasi
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

4.  Role of outer membrane protein H (OmpH)- and OmpA-specific monoclonal antibodies from hybridoma tumors in protection of mice against Pasteurella multocida.

Authors:  M Vasfi Marandi; K R Mittal
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  Peptides representing the specific variable regions but not the full porin proteins can be useful for antibody based diagnosis of typhoid fever.

Authors:  S Kumar; S Kapil; V Gautam; S K Verma; P Ray
Journal:  Folia Microbiol (Praha)       Date:  2010-10-13       Impact factor: 2.099

6.  Antigenic determinants of the OmpC porin from Salmonella typhimurium.

Authors:  S P Singh; S R Singh; Y U Williams; L Jones; T Abdullah
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Reduction of tumor necrosis factor alpha-inducing capacity of recombinant Lactobacillus casei via expression of Salmonella OmpC.

Authors:  A Kajikawa; S Igimi
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

8.  Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus.

Authors:  Elizabeth Acosta-Ramírez; Rebeca Pérez-Flores; Nathalie Majeau; Rodolfo Pastelin-Palacios; Cristina Gil-Cruz; Maricela Ramírez-Saldaña; Nataly Manjarrez-Orduño; Luisa Cervantes-Barragán; Leopoldo Santos-Argumedo; Leopoldo Flores-Romo; Ingeborg Becker; Armando Isibasi; Denis Leclerc; Constantino López-Macías
Journal:  Immunology       Date:  2007-12-07       Impact factor: 7.397

9.  Purification, pore-forming ability, and antigenic relatedness of the major outer membrane protein of Shigella dysenteriae type 1.

Authors:  S Roy; A B Das; A N Ghosh; T Biswas
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Identification of an I-Ed-restricted T-cell epitope of Escherichia coli outer membrane protein F.

Authors:  Kristina M Williams; Elmer C Bigley
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.